. The reasons for the escalating epidemic of diabetes mellitus are multiple, including population ageing, economic development, urbanization, unhealthy eating habits and sedentary lifestyles. Over 90% of diabetes mellitus cases are type 2 diabetes mellitus (T2DM) 3, 4 . However, types of diabetes mellitus are often not distinguished in population-level estimates; therefore, in this Review, the term diabetes mellitus refers to all types of diabetes mellitus unless otherwise specified. Although the genetic architecture might partially determine an individual's response to environmental changes 5 , the main drivers of the global epidemic of T2DM are the rise in obesity, a sedentary lifestyle, energy-dense diets and population ageing 6 . Strong evidence indicates that many cases of T2DM could be prevented by maintaining a healthy body weight, following a healthy diet, exercising daily for at least 30 min, avoiding smoking and consuming alcohol in moderation 7, 8 . In this Review, we describe the global trends of T2DM and its complications. We then discuss the roles of major risk factors, in particular, obesity, lifestyle factors, genetic predispositions, epigenetics and early developmental factors in the epidemic of T2DM and its complications. We highlight evidence from landmark large-scale intervention trials and longitudinal cohort studies from several countries and summarize recommendations for preventing T2DM and its complications.
Global burden of T2DM T2DM and its complications have contributed tremendously to the burden of mortality and disability worldwide. For instance, the Global Burden of Disease Study 2013 identified diabetes mellitus (all forms) as the ninth major cause of reduced life expectancy 9 . In 2010, it was estimated that diabetes mellitus caused 3.96 million deaths in adults aged 20-79 years during that year (6.8% of global mortality) 10 . This estimate was raised to 5.0 million deaths due to diabetes mellitus and its complications during 2015 in an IDF report, which is equivalent to one death every six seconds 1 . The incidence of disability caused by diabetes mellitus has increased substantially 1 Global aetiology and epidemiology of type 2 diabetes mellitus and its complications Yan Zheng 1, 2 , Sylvia H. Ley 2, 4 and Frank B. Hu 2, 3, 4 Abstract | Globally, the number of people with diabetes mellitus has quadrupled in the past three decades, and diabetes mellitus is the ninth major cause of death. About 1 in 11 adults worldwide now have diabetes mellitus, 90% of whom have type 2 diabetes mellitus (T2DM). Asia is a major area of the rapidly emerging T2DM global epidemic, with China and India the top two epicentres. Although genetic predisposition partly determines individual susceptibility to T2DM, an unhealthy diet and a sedentary lifestyle are important drivers of the current global epidemic; early developmental factors (such as intrauterine exposures) also have a role in susceptibility to T2DM later in life. Many cases of T2DM could be prevented with lifestyle changes, including maintaining a healthy body weight, consuming a healthy diet, staying physically active, not smoking and drinking alcohol in moderation. Most patients with T2DM have at least one complication, and cardiovascular complications are the leading cause of morbidity and mortality in these patients. This Review provides an updated view of the global epidemiology of T2DM, as well as dietary, lifestyle and other risk factors for T2DM and its complications. The onset of diabetes mellitus frequently occurs years before the actual diagnosis. Globally, 45.8% (or 174.8 million cases) of all diabetes mellitus cases in adults were estimated to be undiagnosed 13 ; people with undiagnosed and untreated diabetes mellitus are at a greater risk of complications than those who are receiving treatment. Furthermore, medical expenditure for patients with diabetes mellitus is up to three times greater than for the general population without diabetes mellitus 14 . The IDF conservatively estimated that in 2015, US$673 billion (12% of global health expenditure) was spent on treating diabetes mellitus and its related complications Between 2010 and 2030, a 20% increase in the number of adults with diabetes mellitus in developed countries and a 69% increase in developing countries has been predicted 16 . Asia has emerged as the major area with a rapidly developing T2DM epidemic. China and India are the top two epicentres of the global epidemic of T2DM 1 (FIG. 1) . In these countries, the T2DM epidemic is characterized by onset at a lower BMI and younger age than in Western populations 17 . In China, a large-scale population-based survey was used to estimate that in 2010, >113.9 million adults (11.6% of the adult population) had diabetes mellitus and 493.4 million adults (50.1% of the total population) had prediabetes mellitus (impaired glucose tolerance, defined as 2-h oral glucose tolerance levels 7.8-11.0 mmol −l , and impaired fasting glucose, defined as fasting glucose levels 6.1-6.9 mmol −l , according to the WHO criteria) 18 . Less than one-third of those with diabetes mellitus had been previously diagnosed; only one-quarter of patients with diabetes mellitus had been treated, and only 39.7% among those treated had blood levels of HbA 1c < 7.0% 18 . In India, a national study estimated that 62 . Despite a paucity of updated regional data in Africa, IDF 2015 estimated a regional prevalence of 2.1-6.7% in sub-Saharan Africa 1 . According to the Global Burden of Disease report, diabetes mellitus was ranked as one of the leading causes of years of life lost and has a major impact in Latin American countries 24 . On average, 25% of health expenditure in Latin American countries is spent on treating diabetes mellitus and related complications, and the greatest economic burdens were seen in Mexico and Brazil 25 . Notably, given the variations in diagnostic methods and criteria used in individual reports to identify T2DM, along with the lack of national data in developing nations, all the current estimates are likely to be imprecise and are probably an underestimate of current disease burden 26 . The available global estimates and predictions of T2DM highlight the seriousness of the diabetes mellitus pandemic; however, these estimates have limitations. In the IDF report, direct nationwide data were lacking in half of the countries, and their estimates were extrapolated from other similar countries 1 . The accuracy and reliability of such extrapolations might be questionable. In addition, the number of patients with diabetes mellitus globally by 2015 (415 million) has already far surpassed what had been predicted in 2000 for 2030 by both the IDF (324 million) and the WHO (366 million) 2 . Therefore, it is important to use these statistics cautiously and critically, as they are probably underestimates.
With the rising prevalence of childhood obesity in many countries, the prevalence of T2DM is increasing in paediatric populations 27 . Children with T2DM tend to develop complications in early adulthood 27 , which places a substantial burden on the family and society. Given its increasing prevalence, T2DM in childhood has the potential to become a global public health issue. Globally, the incidence and prevalence of T2DM in children and adolescents, with data that is predominantly only available from developed countries, were found to vary widely depending on ethnicity and geographical region 28 . In the USA, the prevalence of T2DM in children and adolescents has increased by 30 28 . T2DM remains fairly uncommon in children under 10 years old, and most youth-onset cases were found in adolescents (10-19 years) 31 . Even so, data from China suggest that the prevalence of childhood T2DM has increased dramatically in the past two decades 32 . In India, preliminary data from a national registry of youth-onset diabetes revealed that 25% of patients with diabetes mellitus who were <25 years old had T2DM 33 . In countries such as the USA, Canada and Australia, the disproportionately higher incidence of T2DM with a trend of earlier age at onset was evident among indigenous populations compared with non-indigenous populations [34] [35] [36] .
Pathophysiology and major risk factors
When the feedback loops between insulin action and insulin secretion do not function properly, the action of insulin in insulin-sensitive tissues such as liver, muscle and adipose tissue (insulin resistance in T2DM) and insulin secretion by pancreatic islet β-cells (β-cell dysfunction in T2DM) are affected, which results in abnormal blood levels of glucose 37 (FIG. 2) . In T2DM, insulin resistance contributes to increased glucose production in the liver and decreased glucose uptake in muscle and adipose tissue at a set insulin level. In addition, β-cell dysfunction results in reduced insulin release, which is insufficient for maintaining normal glucose levels 38 . Both insulin resistance and β-cell dysfunction occur early in the pathogenesis of T2DM, and their critical importance has been verified longitudinally in Pima Indian people progressing from normal glucose tolerance to impaired glucose tolerance to T2DM 39 . In the past three decades, advances in epidemiological research on T2DM have improved our understanding of a wide range of risk factors for the development of T2DM. The determinants of T2DM consist of a matrix of genetic, epigenetic and lifestyle factors (BOX 1) that interact with one another and operate within the larger physicalsociocultural environment. Although individual predisposition to T2DM has a strong genetic basis, evidence from epidemiological studies suggests that many cases of T2DM can be prevented with lifestyle modifications 7, 8 . Nature Reviews | Endocrinology 
Overweight and obesity
The prevalence of T2DM is increasing in parallel with the escalating incidence of obesity in most developed countries, such as the USA 40 , as well as in developing countries, such as China 18, 41, 42 . By contrast, a substantial reduction in the incidence of diabetes mellitus was observed following a population-wide reduction in body weight in the early 1990s in Cuba as a result of an economic crisis 43 . Globally, the age-standardized prevalence of obesity (defined as a BMI ≥30 kg/m 2 ) increased from 3.2% in 1975 to 10.8% in 2014 in men and from 6.4% to 14.9% in women 44 . If these trends continue, the global obesity prevalence is estimated to reach 18% in men and surpass 21% in women by 2025 (REF. 44 ). Excess adiposity, assessed by a high BMI, is the single strongest risk factor for T2DM 8, 45 and is associated with many metabolic abnormalities that result in insulin resistance 46 . In the Nurses' Health Study, 61% of the T2DM cases could be attributed to overweight (defined as a BMI ≥25 kg/m 2 ) 8 . Furthermore, abdominal obesity assessed by waist circumference or waist-hip ratio predicts T2DM risk independent of BMI 47 . Weight gain since young adulthood, which occurs frequently and gradually during the middle life stage, is another independent predictor of T2DM 48 . In addition, visceral adiposity might be an independent predictor for T2DM risk 49 .
In the USA, people of Asian descent are 30-50% more likely to develop diabetes mellitus at a much lower BMI than white people 50 . Such ethnic variations could be attributed to different fat distributions and percentages of body fat. For instance, Asian individuals generally have a higher total body fat percentage at a given BMI 51 and higher visceral adiposity than white people 17 . In addition, abdominal (or central) adiposity, high levels of which increase the risk of T2DM, is highly prevalent in Asian people 52 . Such ethnic heterogeneity in pathophysiology in T2DM could be attributable to the variations in both genetic background and phenotype; for example, Asian people without diabetes mellitus generally have poorer β-cell function than white people without diabetes mellitus 53 .
At an individual level, treatment of obesity with weight loss surgery (for example, bariatric surgery) has proven effective in the prevention and resolution of T2DM 54 . However, this approach is expensive and is unlikely to reverse the current diabetes mellitus epidemic. Thus, population-level strategies for obesity prevention are critical. To address the dual epidemics of obesity and diabetes mellitus, we need to consider the root causes of these diseases, particularly unhealthy diet and lifestyle choices.
Diet and lifestyle factors
Diet and lifestyle modification is an important aspect of T2DM prevention. Major clinical trials have demonstrated that intensive lifestyle interventions can lower the incidence of diabetes mellitus by 58% compared with control groups 55 . Trials have also shown that these interventions are more effective than pharmacological interventions 55 . 57 , have demonstrated that many cases of T2DM could be prevented through lifestyle interventions focused on increasing physical activity and adopting a healthy diet. Nevertheless, when lifestyle interventions are not feasible, pharmacological therapy can be considered as a strategy to prevent the development of T2DM. For example, metformin reduced the incidence of T2DM by 31% over an average follow-up period of 2.8 years among high-risk individuals from the USA who did not have diabetes mellitus 55 . Similarly, metformin reduced T2DM risk in clinical trials in India and China 58 . As trial participants are generally high-risk, they do not represent the general population; therefore, it is difficult to generalize the results from trials to the general population. Evaluating the long-term effects of interventions is also difficult owing to high costs of long-term trials and lack of participant adherence to the intervention. From a public health perspective, the findings from clinical trials in high-risk populations should be considered together with evidence from large-scale observational studies with longer follow-up periods.
Diet. The main evidence from observational and interventional studies on the associations between the risk of T2DM and the intake of nutrients and food groups, as well as dietary patterns, is summarized in TABLE 1. A diet containing high-quality fats and carbohydrates (that is, low in trans fatty acids, high in polyunsaturated fatty acids 59 and with a low glycaemic index and glycaemic Nature Reviews | Endocrinology ) rather than low quality fats and carbohydrates is more important than the relative quantity of these nutrients for T2DM prevention 61 . Dietary recommendations for preventing T2DM typically promote diets rich in whole grains, fruits, vegetables, nuts and legumes and low in refined grains, red or processed meat and sugarsweetened beverages 59 . Adherence to a high-quality diet, such as the Mediterranean diet 62 , was strongly associated with a reduced risk of T2DM. In Asian countries, such as China and South Korea, a rapid nutritional transition in the past two to three decades that was characterized by increased energy intake from sugars, animal products and refined grains and reduced consumption of cereals is a major contributor to the T2DM epidemic 59 . Furthermore, undernutrition (for example, exposure to famine) during early life might increase the risk of T2DM later in life 63 , which is discussed in detail in a subsequent section.
Physical activity. Increased physical activity is an essential component of all effective lifestyle-based trials for the prevention of T2DM. Prospective evidence has shown that both aerobic exercise and resistance training independently have beneficial effects on preventing T2DM 64 . One study has shown that spending more time on moderateintensity and vigorous-intensity physical activity is beneficial for preventing insulin resistance, independent of time spent sedentary 65 . By contrast, another study found that time spent sedentary was associated with an increased risk of T2DM, regardless of physical activity 66 .
Smoking.
A meta-analysis found a dose-response relationship between the number of cigarettes smoked and risk of T2DM, and current smokers had a 45% higher risk of T2DM than non-smokers 67 . Moreover, a high level of exposure to second-hand smoke has been associated with an increased risk of T2DM 68 . Smokers are more likely to have central fat accumulation than non-smokers, and smoking is known to induce insulin resistance and compensatory insulin-secretion responses 69 , which could explain the increased risk of T2DM in people who smoke. Education campaigns to reduce smoking should be a major public health strategy to curb the epidemic of T2DM, especially in China and India, which are epicentres of both T2DM and smoking 70 .
Alcohol intake. Moderate consumption of alcohol has been associated with a reduced risk of T2DM 71 . A meta-analysis of 20 cohort studies found a U-shaped relationship between alcohol consumption and T2DM risk for both sexes, and the lowest risk of diabetes mellitus was observed among people who consumed 1-2 drinks per day 71 . There might be sex differences in the alcohol-T2DM relationship due to potential sex differences in alcohol pharmacokinetics (that is, alcohol processing and elimination), which depend largely on body composition 72 . In a randomized clinical trial involving postmenopausal women, moderate alcohol consumption (about 25 g per day) for 6 weeks improved insulin sensitivity 73 . However, the public health messages around moderate drinking need to be communicated cautiously within a culturally appropriate context, particularly considering the steady increase in alcohol consumption in many Asian countries 74 and the health burden of excess alcohol consumption in eastern Europe 75 .
Genomics and gene-environment interactions
Even though many cases of T2DM could be prevented by maintaining a healthy body weight and adhering to a healthy lifestyle, some individuals with prediabetes mellitus are more susceptible to T2DM than others, which suggests that individual differences in response to lifestyle interventions exist 76 . Substantial evidence from twin and family studies has suggested a genetic basis of T2DM 77 . Over the past decade, successive waves of T2DM genome-wide association studies have identified >100 robust association signals, demonstrating the complex polygenic nature of T2DM 5 . Most of these loci affect T2DM risk through primary effects on insulin secretion, and a minority act through reducing insulin action 78 . Individually, the common variants (minor allele frequency >5%) identified in these studies have only a modest effect on T2DM risk and collectively explain only a small portion (~20%) of observed T2DM heritability 5 . It has been hypothesized that lower-frequency variants could explain much of the remaining heritability 79 . However, results of a large-scale sequencing study from the GoT2D and T2D-GENES consortia, published in 2016, do not support such a hypothesis 5 . Genetic variants might help reveal possible aetiological mechanisms underlying T2DM development; however, the variants identified thus far have not enabled clinical prediction beyond that achieved with common clinical measurements, including age, BMI, fasting levels of glucose and dyslipidaemia. A study published in 2014 linked susceptibility variants to quantitative glycaemic traits and grouped these variants on the basis of their potential intermediate mechanisms in T2DM pathophysiology: four variants fitted a clear insulin resistance pattern; two reduced insulin secretion with fasting hyperglycaemia; nine reduced insulin secretion with normal fasting glycaemia; and one altered insulin processing 80 . Considering such evidence, the genetic architecture of T2DM is highly polygenic, and thus, substantially larger association studies are needed to identify most T2DM loci, which typically have small to modest effect sizes 81 . The missing heritability of T2DM could be accounted for by the interactions between susceptibility loci and various environmental determinants, whereby the impact of a given genetic variant is modified by the environmental milieu (and vice versa). Evidence that lifestyle factors modify the genetic effects on T2DM risk has been generated from both observational studies and clinical trials 82 . However, genetic background might also affect the individual's response to lifestyle interventions 83 . In addition, replication data are sparse, and comprehensive, large-scale studies have failed to provide a compelling basis for the significant interaction effect 84, 85 . This failure might have occurred because the interaction effects are of small magnitude or might be due to the limited statistical power and multiple sources of bias and confounding factors in the current research methods 86 .
Biomarkers and metabolomics
Over the past two decades, biomarkers from the pathways of abnormal adipocyte signalling, subclinical inflammation, endothelial dysfunction and iron overload have improved our understanding of the complexity of T2DM pathophysiology, beyond the classic triumvirate of β-cell, skeletal muscle and liver 87 . However, the ability of these biomarkers to predict future risk of T2DM beyond anthropometric measures, lifestyle factors and fasting levels of glucose and lipids is still debatable 87 . Within the past 7 years, a complementary, novel set of T2DM biomarkers has largely been generated by metabolomic studies, which systematically analyse metabolites (low molecular weight biochemicals) in a biological sample. A meta-analysis of published metabolomics studies that was published in 2016 revealed that the high circulating levels of hexoses, branched-chain amino acids, aromatic amino acids, phospholipids and triglycerides, were associated with the incidence of prediabetes mellitus and T2DM 88 . As downstream end products, levels of these metabolites could reflect upstream gene function and environmental influences, as well as their complex interplays. Of note, the metabolomics-derived indices enable statistically significant improvement in the prediction of T2DM risk beyond the use of traditional risk factors 89 .
Developmental origins of T2DM
The thrifty genotype hypothesis postulates that thrifty genotypes favouring efficient metabolism and storage of energy were positively selected for as a result of evolutionary selection by repeated feast and famine cycles; these genotypes are maladaptive in many modern environments 90 . This hypothesis has been widely used to explain the disproportionate burden of T2DM among indigenous populations (worldwide, >50% of indigenous adults >35 years old are estimated to have T2DM) 91 . This selection might have led to increased vulnerability to diabetes mellitus among indigenous populations at a time of rapid transition to a high-calorie diet and physical inactivity 91 . In contrast to the thrifty genotype hypothesis, the thrifty phenotype hypothesis (developmental origins) postulates a mismatch between early developmental environments (intrauterine) and adulthood environments. This hypothesis proposes that the adaptations in response to fetal undernutrition that lead to metabolic and structural changes (for example, decreased β-cell mass and function and increased insulin resistance) are beneficial for early survival but might increase the risk of chronic diseases, such as T2DM, in adulthood 92 . Low birthweight, a widely T2DM, type 2 diabetes mellitus. *For the different categories of nutrients and food groups, such as the tertiles, quartiles or quintiles, the effect estimates and corresponding 95% CIs of extreme groups were calculated by comparing the highest and lowest categories in a meta-analysis.
used indicator of fetal undernutrition, is associated with an increased risk of T2DM in adult life 93 . Epidemiological evidence from the Dutch Hunger Winter of 1944 -1945 ) and the Chinese famine of 1958 -1962 shows that children born during a famine who are exposed to intrauterine undernutrition but live in an obeso genic environment as an adult have an increased risk of chronic diseases (including T2DM). Epigenetic processes could be a central underlying mechanism of this thrifty phenotype hypothesis, leading to altered feeding behaviour, insulin secretion and action and even transgenerational risk transmission 95 . Gestational diabetes mellitus, which is a common pregnancy complication defined as glucose intolerance with onset or first recognition during pregnancy 96 , is another risk factor that influences T2DM risk in exposed women and their offspring. The prevalence of gestational diabetes mellitus varies depending on the diagnostic criteria used and the study population; for instance, the prevalence is 1.2-3.1% of pregnancies in European countries (except for Italy) and 1.9-13.7% of pregnancies in the southeast Asia region 97 . Women with gestational diabetes mellitus had a sevenfold increased risk of developing T2DM compared with those who had a normoglycaemic pregnancy 98 . In the offspring of women with gestational diabetes mellitus, exposure to intrauterine hyperglycaemia is a strong risk factor for T2DM 96 . The increasing frequency of exposure to gestational diabetes mellitus in utero, together with increasing body weight, accounted for most of the increase in the prevalence of T2DM in Pima Indian children 99 . Given its global influence, it is essential to break the vicious cycle of diabetes mellitus begetting diabetes mellitus over generations by implementing effective strategies to prevent gestational diabetes mellitus.
Other factors
Interest in the role of the gut microbiome in the development of T2DM has exploded in the past few years, and variation in the diversity and composition of the gut microbiota has been tied to T2DM 100 . For example, levels of butyrate-producing bacteria are decreased in the gut microbiota of patients with T2DM compared with that of healthy individuals 101 . In addition, evidence suggests that ambient air pollution is an emerging risk factor for T2DM 102 , especially in developing countries where the rapid increase in urbanization has introduced high levels of outdoor and indoor pollution 103, 104 . Furthermore, the use of some medications, such as statins, thiazides and beta-blockers, has been associated with an increased risk of T2DM 105 .
Epidemiology of complications in T2DM
The complications of diabetes mellitus have traditionally been divided into macrovascular complications (for example, cardiovascular disease (CVD)) and microvascular complications (for example, complications affecting the kidney, the retina and the nervous system). Complications of T2DM are very common, with half of patients with T2DM presenting with microvascular complications and 27% with macrovascular complications in an observational study of 28 countries in Asia, Africa, South America and Europe 106 . On the basis of cohort studies from developed countries, the relative risk of microvascular disorders and macrovascular disorders among patients with diabetes mellitus was estimated to be at least 10-20 times higher and 2-4 times higher, respectively, than in people without diabetes mellitus 107 . In most developing countries, patients with diabetes mellitus are at a particularly increased risk of developing kidney complications and stroke (but have a reduced risk of coronary heart disease) compared with patients in developed countries 108 .
The large increase in the number of prevalent cases of diabetes mellitus and undiagnosed diabetes mellitus, together with advances in the treatment of T2DM meaning that people are living longer with the condition than they used to, has resulted in a costly increase in the incidence of diabetic complications; for instance, 53% of the lifetime medical costs of T2DM have been attributed to treating the major complications of T2DM (nephropathy, neuropathy, retinopathy, stroke and coronary heart diseases) in the USA 109 . However, the absence of internationally recognized and standardized classification, definition or diagnostic criteria for the complications of T2DM makes it hard to precisely estimate their contributions to morbidity and mortality 26 . Patient-centred management of T2DM involves lifestyle modification and combination therapy of medication 110 . In some developed countries, the management of T2DM, mainly through glycaemic control and cardiovascular risk management, has resulted in improved care; however, for the rest of the world, such data are scarce 107 .
Cardiovascular disease
CVD, including coronary heart disease, peripheral vascular disease and cerebrovascular disease, is the primary cause of morbidity and mortality in the USA 21 . In patients with T2DM, CVD typically develops 14.6 years earlier 111 , and with greater severity, than in individuals without diabetes mellitus 112 . Furthermore, individuals with T2DM are twice as likely to develop CVD as those without T2DM, independent of age, smoking status, BMI and systolic blood pressure 113 , and diabetes mellitus has been associated with a more than doubled risk of death from vascular causes 114 . This excess risk disproportionately affects women 115 such that diabetes mellitus eliminates or attenuates the reduced risk of CVD that is generally seen in premenopausal women. Post hoc analysis of data from the large-scale, randomized clinical trial Action in Diabetes and Vascular Disease (ADVANCE) has suggested that patients from Asian countries who have T2DM have a lower risk of major coronary events than patients from eastern Europe or Established Market Economies 116 . Within Asia, susceptibility to vascular complications varies across ethnicities and areas. For example, patients in China with diabetes mellitus had lower rates of coronary artery disease than patients in other countries 117 , whereas patients in India who had T2DM had a doubled risk of coronary artery disease-related deaths compared with white Europeans who had T2DM, independent of traditional risk factors 118 . Coronary artery disease detection and diabetes mellitus duration in these studies might partially account for the ethnic differences.
Renal disease
Approximately 10% of deaths in people with T2DM are attributable to renal failure 119 . Diabetes mellitus causes 44% of the incident cases of end-stage renal disease (ESRD) in the USA 21 . Furthermore, in the USA, about 25% of patients with T2DM have diabetic kidney disease, which is defined as persistent albuminuria, persistent reduced estimated glomerular filtration rate or both 120 . In China, glomerulonephritis was historically the leading cause of ESRD; however, diabetes-related chronic kidney disease was the leading cause of ESRD in the general population in 2010 and has been the leading cause in hospitalized patients since 2011 (REF. 121 ). In North America, diabetes-related ESRD is 80% more prevalent in patients with T2DM of Asian descent than in patients who are white 122 . Furthermore, the risk of diabetic kidney disease is much higher in Asian countries than in Western countries 17 . The ADVANCE trial has confirmed the increased frequency of renal disease in patients with diabetes mellitus in Asia compared with white patients in eastern Europe and Established Market Economies 116 . Genetic background, lifestyle and patient awareness of complications might account for these ethnic differences in renal disease among patients with diabetes mellitus 123 .
Other complications
The prevalence of diabetic retinopathy is approximately 28.5% in the USA 124 and ranges from 16% to 35% in Asian countries 125, 126 . T2DM is the leading cause of non-traumatic lower-limb amputations in the USA 21 . In the UK, about one in three amputees has diabetes mellitus 127 , and in Australia, about half of amputees have diabetes mellitus 128 . Directly or indirectly, T2DM might also increase the risks of disorders in the musculoskeletal, hepatic and digestive systems, as well as cognitive function and mental health disorders, and could increase the incidence of some cancers, for instance, those of the liver, pancreas and endometrium 129 . Several key comorbidities, such as non-alcoholic fatty liver disease 130 , obstructive sleep apnoea 131 and depression 132 , are associated with T2DM bi-directionally, and such interrelationships are at least partially caused by obesity. However, the paucity of population-level data on the associations of T2DM with these diseases and other complications, such as infections and neuropathy, is a major gap in population-level monitoring.
T2DM management
Modification of lifestyle, including weight loss, increasing physical activity and adopting a healthy diet, remains one of the first-line strategies for the management of T2DM. In the Look AHEAD (Action for Health in Diabetes) trial in the USA 133 , a 4-year intensive lifestyle intervention through caloric restriction and increased physical activity achieved increased weight loss, improved cardiometabolic risk profiles and a reduced requirement for medication to control CVD risk factors compared with the control group (who had diabetes mellitus and received support and education about lifestyle modifications) 134 . However, after a median follow-up period of 9.6 years, the trial was terminated because the intervention did not reduce the rate of CVD events 134 .
Another randomized, controlled trial in the USA, the Health Benefits of Aerobic and Resistance Training in Individuals with Diabetes (HART-D) trial, found that HbA 1c levels were reduced in the group that undertook combined resistance and aerobic training after the 9-month exercise program, but not in the group that undertook either resistance training or aerobic training alone 135 . These findings suggest that it is more beneficial to combine both aerobic and resistance exercises than to perform only one type of exercise when time available to exercise is limited 136 . The post hoc subgroup analysis of data from the PREDIMED trial, which was conducted in Spain, revealed that a Mediterranean diet significantly reduced CVD risk (by ~30%) in participants with diabetes mellitus 137 . Furthermore, a Mediterranean diet enriched with extra-virgin olive oil might protect against diabetic retinopathy, but not against diabetic nephropathy 138 . In addition to lifestyle modification, social support has an important role in T2DM management as it directly affects the performance of diabetes mellitus self-care behaviours and indirectly affects glycaemic control 139 . For example, patients whose family members exhibit non-supportive behaviours have reduced adherence to diabetes mellitus medication regimens 140 . Public health and social interventions through a multifaceted systems approach, involving structural changes in schools, workplaces, communities, media and food and beverage systems, have been proposed to address the pandemic of obesity 141 , and these are also applicable to T2DM prevention and management.
Conclusions
In the past three decades, T2DM and its complications have reached epidemic levels, particularly in developing countries. T2DM is a global crisis that threatens the health and economy of the world. Approximately 1 in every 11 adults has T2DM globally, and about 75% of patients with diabetes mellitus live in developing countries 1 . T2DM is associated with an 8-year reduction in lifespan in the USA 142 , and also has a negative effect on quality of life as most patients also have complications. About 12% of the global health expenditure was spent on treatment of T2DM and its related complications in 2015 (REF. 1 ).
An accumulating body of evidence from large prospective observational studies and randomized clinical trials indicates that many cases of T2DM could be prevented by maintaining a healthy body weight with a focus on maintaining energy balance by engaging in regular physical activity and consuming a healthy diet 7, 8 . Preventing and managing gestational diabetes mellitus to stop the vicious cycle in which diabetes mellitus begets diabetes mellitus is also key. The mismatch between early developmental environment (for example, fetal undernutrition) and obesogenic adulthood environment is an important risk factor for T2DM. For T2DM management, lifestyle modification, social support and medication adherence are important for reducing the risk of cardiovascular and other complications.
